These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 11384774)

  • 1. Inflammatory response to cold injury in remote organs is reduced by corticotropin-releasing factor.
    Bozkurt A; Ghandour S; Okboy N; Oner S; Arbak S; Coşkun T; Yeğen BC
    Regul Pept; 2001 Jun; 99(2-3):131-9. PubMed ID: 11384774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Corticotropin-releasing factor inhibits the acute inflammatory response of rat pawskin to cold injury.
    Serda SM; Wei ET
    Cryobiology; 1991 Apr; 28(2):185-90. PubMed ID: 2070621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Putative neuroprotective role of centrally administered corticotropin-releasing factor in low-temperature-exposed neonatal chicks.
    Mujahid A; Furuse M
    Neuroscience; 2009 Feb; 158(4):1571-6. PubMed ID: 19118602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reduction in vesicant-induced cellular inflammation and hyperalgesia by local injection of corticotropin releasing factor in rabbit eyelid.
    McLoon LK; Sandnas AM; Nockleby KJ; Wirtschafter JD
    Inflamm Res; 2002 Jan; 51(1):16-23. PubMed ID: 11845996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intracisternal sauvagine is more potent than corticotropin-releasing factor to decrease gastric vagal efferent activity in rats.
    Kosoyan HP; Wei JY; Taché Y
    Peptides; 1999; 20(7):851-8. PubMed ID: 10477086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Gastroprotective action of corticotropin-releasing factor (CRF): involvement of glucocorticoids and CRF receptors type 2].
    Filaretova LP; Bagaeva TR; Morozova OIu
    Ross Fiziol Zh Im I M Sechenova; 2012 Dec; 98(12):1555-66. PubMed ID: 23461199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peripheral injection of a new corticotropin-releasing factor (CRF) antagonist, astressin, blocks peripheral CRF- and abdominal surgery-induced delayed gastric emptying in rats.
    Martínez V; Rivier J; Taché Y
    J Pharmacol Exp Ther; 1999 Aug; 290(2):629-34. PubMed ID: 10411571
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local injections of corticotropin releasing factor reduce doxorubicin-induced acute inflammation in the eyelid.
    McLoon LK; Wirtschafter J
    Invest Ophthalmol Vis Sci; 1997 Apr; 38(5):834-41. PubMed ID: 9112978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Corticotropin-releasing factor: an inhibitor of vascular leakage in rat skeletal muscle and brain cortex after injury.
    Wei ET; Gao GC
    Regul Pept; 1991 Apr; 33(2):93-104. PubMed ID: 1882088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of Central Corticotropin-Releasing Factor on Hepatic Lipid Metabolism and Inflammation-Related Gene Expression in Rats.
    Nakade Y; Kitano R; Yamauchi T; Kimoto S; Sakamoto K; Inoue T; Kobayashi Y; Ohashi T; Sumida Y; Ito K; Yoneda M
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33920431
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the long-term administration of corticotropin-releasing factor on the pituitary-adrenal and pituitary-gonadal axis in the male rat.
    Rivier C; Vale W
    J Clin Invest; 1985 Feb; 75(2):689-94. PubMed ID: 2982917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrahypothalamic corticotropin-releasing factor elevates gastric bicarbonate and inhibits stress ulcers in rats.
    Gunion MW; Kauffman GL; Taché Y
    Am J Physiol; 1990 Jan; 258(1 Pt 1):G152-7. PubMed ID: 2301576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urocortin, a corticotropin-releasing factor-related mammalian peptide, inhibits edema due to thermal injury in rats.
    Turnbull AV; Vale W; Rivier C
    Eur J Pharmacol; 1996 May; 303(3):213-6. PubMed ID: 8813571
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of corticotropin-releasing factor type 1 (CRF1) receptor messenger ribonucleic acid in the paraventricular nucleus of rat hypothalamus by exogenous CRF.
    Mansi JA; Rivest S; Drolet G
    Endocrinology; 1996 Nov; 137(11):4619-29. PubMed ID: 8895325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central administration of corticotropin releasing factor alters rat pup isolation calls.
    Insel TR; Harbaugh CR
    Pharmacol Biochem Behav; 1989 Jan; 32(1):197-201. PubMed ID: 2786637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral anti-inflammatory actions of corticotropin-releasing factor.
    Wei ET; Gao GC; Thomas HA
    Ciba Found Symp; 1993; 172():258-68; discussion 268-76. PubMed ID: 7683982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [D-Pro5]Corticotropin-releasing factor analogs as selective agonists at corticotropin-releasing factor receptors.
    Wei ET; Thomas HA; Price JS; Kishimoto T
    Eur J Pharmacol; 1996 Jun; 306(1-3):161-4. PubMed ID: 8813628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Metyrapone effect on gastroprotective action of corticotropin-releasing factor administered centrally against indomethacin-induced gastric injury].
    Miazina MA; Bagaeva TR; Filaretova LP
    Ross Fiziol Zh Im I M Sechenova; 2014 Dec; 100(12):1421-30. PubMed ID: 25936181
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 1 beta and corticotropin-releasing factor inhibit pain by releasing opioids from immune cells in inflamed tissue.
    Schäfer M; Carter L; Stein C
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4219-23. PubMed ID: 7910403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increase of core temperature induced by corticotropin-releasing factor and urocortin: a comparative study.
    Figueiredo MJ; Fabricio AS; Machado RR; Melo MC; Soares DM; Souza GE
    Regul Pept; 2010 Dec; 165(2-3):191-9. PubMed ID: 20691217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.